Healthcare

Latest filings from the Healthcare sector

New Product Small Cap

Dr. Lal PathLabs Launches India’s First Comprehensive Complement Lab

Dr. Lal PathLabs Ltd
•
Healthcare Services
Business Update Micro Cap

SMS Pharmaceuticals’ Associate Gains US FDA Approval for Ranitidine

SMS Pharmaceuticals Ltd
•
Pharmaceuticals & Biotechnology
New Product Mid Cap

Glenmark Launches World’s First Nebulized Triple Therapy for COPD

Glenmark Pharmaceuticals Ltd
•
Pharmaceuticals & Biotechnology
Acquisitions & Mergers Small Cap

Eris Lifesciences Acquires Remaining 30% of Swiss Parenterals

Eris Lifesciences Ltd
•
Pharmaceuticals & Biotechnology
Business Update Large Cap

Dr. Reddy’s Gains EU Approval for AVT03 Biosimilar of Prolia® and Xgeva®

Dr Reddys Laboratories Ltd
•
Pharmaceuticals & Biotechnology
Business Update Small Cap

Natco Pharma Concludes USFDA Inspection at Chennai API Unit

Natco Pharma Ltd
•
Pharmaceuticals & Biotechnology
New Product Mid Cap

Alkem Laboratories Introduces DSS Probiotic in India

Alkem Laboratories Ltd
•
Pharmaceuticals & Biotechnology
Business Update Small Cap

Sun Pharma Resubmits PDP-716 NDA Response to US FDA

Sun Pharma Advanced Research Company Ltd
•
Pharmaceuticals & Biotechnology
Business Update Small Cap

Marksans Pharma Subsidiary Gains UK MHRA Approval for Cetirizine

Marksans Pharma Ltd
•
Pharmaceuticals & Biotechnology
Quarterly Results Small Cap

Granules India Reports 34% Revenue Growth in Q2 FY26 Earnings Call

Granules India Ltd-$
•
Pharmaceuticals & Biotechnology
Business Update Small Cap

Marksans Pharma Inc Receives USFDA Approval for Loperamide Tablets

Marksans Pharma Ltd
•
Pharmaceuticals & Biotechnology
Business Update Small Cap

Solara Completes US FDA Inspection at Mangalore Facility

SOLARA ACTIVE PHARMA SCIENCES Ltd
•
Pharmaceuticals & Biotechnology
Business Update Mid Cap

Glenmark and Cosmo Secure EU Approval for Acne Treatment Winlevi

Glenmark Pharmaceuticals Ltd
•
Pharmaceuticals & Biotechnology
Strategic Partnership Large Cap

Sun Pharma and AstraZeneca Partner for Hyperkalaemia Treatment in India

Sun Pharmaceutical Industries Ltd
•
Pharmaceuticals & Biotechnology
Business Update Small Cap

Marksans Pharma’s Subsidiary Relonchem Gains UK MHRA Approval

Marksans Pharma Ltd
•
Pharmaceuticals & Biotechnology
New Product Small Cap

Shilpa Medicare Launches NODUCATM for MAFLD Treatment in India

Shilpa Medicare Ltd
•
Pharmaceuticals & Biotechnology
New Product Small Cap

Fischer Medical’s Subsidiary Launches Low-Field MRI for Aneurysm Screening

Fischer Medical Ventures Ltd
•
Healthcare Equipment & Supplies
Business Update Small Cap

Alembic Pharmaceuticals Gains USFDA Approval for Diltiazem Tablets

Alembic Pharmaceuticals Ltd
•
Pharmaceuticals & Biotechnology
Order Wins Small Cap

Fabtech Technologies Secures USD 7.8M Order in Saudi Arabia

Fabtech Technologies Ltd
•
Healthcare Services
Business Update Large Cap

Lupin Launches Risperidone Injectable with 180-Day CGT Exclusivity in U.S.

Lupin Ltd
•
Pharmaceuticals & Biotechnology